Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PE0D
|
|||
| Former ID |
DIB003577
|
|||
| Drug Name |
Nuleusin
|
|||
| Synonyms |
IL-2 (subcutaneous formulation, RCC/MM), 3SBio
Click to Show/Hide
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Discontinued in Phase 3 | [1] | |
| Company |
3SBio Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027551) | |||
| REF 2 | Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris. Protein Expr Purif. 2012 Jul;84(1):154-60. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.